title: Increased plasma citrulline in mice marks diet-induced obesity and may predict the development of the metabolic syndrome.
abstract: In humans, plasma amino acid concentrations of branched-chain amino acids (BCAA) and aromatic amino acids (AAA) increase in states of obesity, insulin resistance and diabetes. We here assessed whether these putative biomarkers can also be identified in two different obesity and diabetic mouse models. C57BL/6 mice with diet-induced obesity (DIO) mimic the metabolic impairments of obesity in humans characterized by hyperglycemia, hyperinsulinemia and hepatic triglyceride accumulation. Mice treated with streptozotocin (STZ) to induce insulin deficiency were used as a type 1 diabetes model. Plasma amino acid profiling of two high fat (HF) feeding trials revealed that citrulline and ornithine concentrations are elevated in obese mice, while systemic arginine bioavailability (ratio of plasma arginine to ornithine + citrulline) is reduced. In skeletal muscle, HF feeding induced a reduction of arginine levels while citrulline levels were elevated. However, arginine or citrulline remained unchanged in their key metabolic organs, intestine and kidney. Moreover, the intestinal conversion of labeled arginine to ornithine and citrulline in vitro remained unaffected by HF feeding excluding the intestine as prime site of these alterations. In liver, citrulline is mainly derived from ornithine in the urea cycle and DIO mice displayed reduced hepatic ornithine levels. Since both amino acids share an antiport mechanism for mitochondrial import and export, elevated plasma citrulline may indicate impaired hepatic amino acid handling in DIO mice. In the insulin deficient mice, plasma citrulline and ornithine levels also increased and additionally these animals displayed elevated BCAA and AAA levels like insulin resistant and diabetic patients. Therefore, type 1 diabetic mice but not DIO mice show the "diabetic fingerprint" of plasma amino acid changes observed in humans. Additionally, citrulline may serve as an early indicator of the obesity-dependent metabolic impairments.
authors.affiliation: Molecular Nutrition Unit, Research Center for Nutrition and Food Sciences, Technische Universität München, Freising-Weihenstephan, Germany.
authors.forename: Manuela
authors.initials: M
authors.lastname: Sailer
authors.forename: Christoph
authors.initials: C
authors.lastname: Dahlhoff
authors.forename: Pieter
authors.initials: P
authors.lastname: Giesbertz
authors.forename: Mena K
authors.initials: MK
authors.lastname: Eidens
authors.forename: Nicole
authors.initials: N
authors.lastname: de Wit
authors.forename: Isabel
authors.initials: I
authors.lastname: Rubio-Aliaga
authors.forename: Mark V
authors.initials: MV
authors.lastname: Boekschoten
authors.forename: Michael
authors.initials: M
authors.lastname: Müller
authors.forename: Hannelore
authors.initials: H
authors.lastname: Daniel
mesh_terms: D024322:Amino Acids, Aromatic / Q000097:blood; D000818:Animals; D002956:Citrulline / Q000097:blood* / Q000378:metabolism; D059305:Diet, High-Fat / Q000009:adverse effects*; D007328:Insulin / Q000172:deficiency; D007421:Intestine, Small / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications*; D051379:Mice; D008810:Mice, Inbred C57BL; D018482:Muscle, Skeletal / Q000378:metabolism; D009765:Obesity / Q000097:blood* / Q000150:complications* / Q000209:etiology / Q000378:metabolism; D009952:Ornithine / Q000097:blood / Q000378:metabolism
chemical_list: D024322:Amino Acids, Aromatic; D007328:Insulin; D002956:Citrulline; D009952:Ornithine